10X Genomics (TXG) PT Lowered to $20 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Puneet Souda lowered the price target on 10X Genomics (NASDAQ: TXG) to $20.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
